Introduction
Surgical aortic valve replacement (SAVR) is currently the standard of care to treat patients with severe symptomatic aortic stenosis (AS) and is generally accepted to alleviate symptoms and prolong survival. Based on the results of randomized trials, transcatheter aortic valve implantation (TAVI) is the new standard of care for patients with symptomatic AS who are deemed 'inoperable'. Debatably, TAVI is also an alternative to SAVR in selected patients who are at high risk but operable. 1 The technique of TAVI is thought to be reaching maturity, although several clinical problems associated with the treatment of such high-risk patients remain, with the anesthetic management during TAVI being controversial. 2 Soon after the introduction of TAVI, general anesthesia (GA) with endotracheal intubation was usually chosen, despite differences in the approach site used for this procedure. Recently, a few studies have demonstrated the feasibility of TAVI with the patient under local anesthesia with conscious sedation (LACS), owing to the increased experience of the technique and improved devices. 8e10 GA ensures patient stability during TAVI, is more comfortable for the operator, and facilitates the management of procedural complications and the use of transesophageal echocardiography. The many possible disadvantages of GA compared to LACS, include a requirement for tracheal intubation and mechanical ventilation, delayed extubation, hemodynamic instability, a lack of continuous neurologic monitoring, and prolonged intensive care unit and hospital stays. The LACS has the advantages of being less invasive, shorter procedure time, shorter intensive care unit stay, earlier recovery, shorter hospital stay and a significant reduction in labor costs than the GA group. 2 GA also may not be feasible for patients with unsuitable airways and severe respiratory comorbidities. We hereby present the first Indian experience of TAVI under LACS in patients unsuitable for GA.
We hereby present the first Indian experience of two patients who underwent TAVI under LACS as they were unsuitable for GA.
2.
Case I
A 79-year old gentleman deemed unsuitable for SAVR was evaluated for TAVI at our institute. His Euroscore was 36. During pre-procedure evaluation the CT aortography showed a superior mediastinal mass. This mass was large and compressing the trachea significantly. The anaesthetist was of the opinion that it would be difficult to intubate the patient in view of more than 50% narrowing of the trachea by the thyroid mass which was pressing it from posterior aspect. In view of the benign nature of the thyroid mass, its removal was deferred. TAVI was performed successfully under LACS with inj xylocaine locally, inj midazolam 0.05 mg/kg and fentanyl I mgm/kg IV bolus followed by a target controlled infusion of propofol 10 to 75 mg/kg/min adjusted according to the response.
Case II
The second case was a 79-year old gentleman at very high risk for SAVR with a Euroscore of 40. He was a known case of chronic bronchial asthma. He was planned for TAVI under general anaesthesia but developed acute severe asthma in hospital one day before the procedure. Asthmatic episode was managed and plan was changed from general anaesthesia to local anesthesia with conscious sadation. Conscious sedation was done similar to Case-I with inj xylocaine locally, inj midazolam 0.05 mg/kg and fentanyl I mgm/kg IV bolus followed by a target controlled infusion of propofol 10 to 75 mg/kg/min adjusted according to the response. TAVI was carried out successfully in 45 minutes. He remained stable without any respiratory complications during and after procedure.
Discussion
About 30e40% of patients with severe aortic stenosis remain unfit for SAVR due to significant comorbidities and advanced medical condition and this cohort of patients is supposed to increase, reflecting the aging population and improving therapeutic options. 11 Transcatheter aortic valve implantation (TAVI) has emerged as a novel alternative procedure that enables catheter-based treatment in unsuitable/high-risk surgical aortic valve replacement patients. The technique of TAVI is improving rapidly, but the anaesthetic management remains controversial. 2 The aim of the anaesthesia remains to provide less invasive anesthesia/anaelgesia without compromising on the safety and comfort of the patient. From the beginning of the procedure general anesthesia has been the most common mode of anaesthetizing the patients for TAVI. General anesthesia not only allays the anxiety in the patients and operators mind but allows the use of intra procedural transesophageal echo imaging. TEE helps in correct positioning of the valve; valve retrieval in case of inappropriate placement; quick detection and easy handling of an intra procedural complication like severe AR and Hemopericardium. On the other hand GA is not free of the risks in this frail elderly population with comorbidities, bad lungs, poor renal clearance and risks of procedure or anaesthesia related cerebral ischaemia. GA increases procedure time, ICU/hospital stay, labor costs and may not be feasible for patients unsuitable for endotracheal intubation and severe respiratory illness. 11 LACS is less invasive, reduces procedural time, decreases ICU/hospital stay and labor costs, however there may be a failure rate of about 4e11% leading to conversion of LACS to GA. The causes for failure like cardiac arrest, myocardial infarction, cardiac temponade, stroke, shock after balloon valvuloplasty and requirement of a high access retroperitoneal approach are procedure related and unrelated to the anesthetic approach. 2 One of our patients had a superior mediastinal mass and the other chronic severe bronchial asthma, both deemed relatively unsuitable for GA by the anesthesia team. The procedures were carried out under LACS successfully in just 45 minutes in both the patients. Both were shifted to monitored rooms in one day and discharged on day 5.
Conclusion
Local anesthesia with conscious sedation may be an effective alternative to general anesthesia for TAVI in general and particularly in patients unsuitable for endotracheal intubation and severe respiratory comorbidities.
